Pediatric Pharmacotherapy

• Proton Pump Inhibitor Use in Infants and Children PPIs are approved for use in pediatric patients, but these drugs have been associated with some potentially serious adverse effects. Find out what there is to know.
  Pediatric Pharmacotherapy, August 2019
• Dupilumab Use in Moderate-to-Severe Atopic Dermatitis The recent FDA approval of dupilumab offers another option for the treatment of moderate to severe atopic dermatitis in adolescents.
  Pediatric Pharmacotherapy, July 2019
• Use of Ceftazidime-Avibactam in Infants and Children Ceftazidime-avibactam is now approved for the treatment of gram-negative bacterial infections in pediatric patients. Find out what there is to know.
  Pediatric Pharmacotherapy, June 2019
• Pediatric Updates From the Food and Drug Administration Get up-to-date on the latest updates from the FDA regarding potential treatment options for pediatric patients.
  Pediatric Pharmacotherapy, June 2019
• Methylphenidate Capsules for Morning ADHD Symptom Control Newly approved delayed- and extended-release methylphenidate capsules designed for bedtime administration may provide better early morning symptom control for ADHD patients.
  Pediatric Pharmacotherapy, May 2019
• Baloxavir Marboxil: A Flu Antiviral With a Novel Mechanism Baloxavir marboxil is a newly approved treatment for influenza. Learn more about the antiviral mechanism of action of this agent.
  Pediatric Pharmacotherapy, April 2019
• Update on the Use of Tacrolimus in Pediatrics Tacrolimus is commonly used for the prophylaxis of organ rejection after transplantation. This article provides an update for its use in children.
  Pediatric Pharmacotherapy, March 2019
• Cannabidiol Use in Refractory Epilepsy The recent FDA approval of cannabidiol provides another treatment option for refractory epilepsy. Find out what there is to know.
  Pediatric Pharmacotherapy, February 2019
• Stiripentol Use in Children With Refractory Seizures This article summarizes current knowledge regarding the use of stiripentol as an add-on therapy for the treatment of refractory seizures in children.
  Pediatric Pharmacotherapy, January 2019
• Posaconazole Use in Infants and Children This article provides an update regarding the use of posaconazole for antifungal prophylaxis and treatment in pediatric patients.
  Pediatric Pharmacotherapy, December 2018
• A Reappraisal of Ciprofloxacin Use in Infants and Children This article provides a reassessment of pediatric ciprofloxacin utilization in light of the recent FDA drug safety communication.
  Pediatric Pharmacotherapy, November 2018
• Update on Levetiracetam in Infants and Children This article provides an update regarding the use and safety of levetiracetam in the treatment of pediatric epilepsy.
  Pediatric Pharmacotherapy, September 2018
• Fosaprepitant and Aprepitant for CINV in Children Aprepitant and fosaprepitant have been approved for use in pediatric patients for the prevention of chemotherapy-induced nausea and vomiting.
  Pediatric Pharmacotherapy, August 2018
• Use of Acetaminophen for Patent Ductus Arteriosus Closure This article provides an update regarding the use of acetaminophen to close a patent ductus arteriosus.
  Pediatric Pharmacotherapy, July 2018
• News for Pediatric Healthcare Providers From the FDA Which drugs have been newly developed or indicated for pediatric patients? Find out what there is to know.
  Pediatric Pharmacotherapy, June 2018
• A Third Dose of the MMR Vaccine During Mumps Outbreaks Could the administration of a third dose of the MMR vaccine add an additional layer of protection during mumps outbreaks?
  Pediatric Pharmacotherapy, May 2018
• Treatment of Status Epilepticus What are the latest therapeutic options for status epilepticus?
  Pediatric Pharmacotherapy, April 2018
• Drug Fever: Recent Cases From the Medical Literature A review of recent case reports provides insight into the symptoms of drug fever and the agents that have been associated with this condition.
  Pediatric Pharmacotherapy, February 2018
• Extended-Release Methylphenidate Oral Tablets A newly approved extended-release formulation of methylphenidate may be another option for the management of ADHD in children.
  Pediatric Pharmacotherapy, December 2017
• New Drug Approvals and New Pediatric Indications Which drugs are newly indicated for use in pediatric patients? This article provides an update.
  Pediatric Pharmacotherapy, November 2017